Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Invested Capital: 2023-2025

Historic Return on Invested Capital for Kiniksa Pharmaceuticals International (KNSA) over the last 1 years, with Sep 2025 value amounting to 0.05%.

  • Kiniksa Pharmaceuticals International's Return on Invested Capital rose 11.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 11.00%. This contributed to the annual value of -0.04% for FY2023, which is N/A change from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Return on Invested Capital of 0.05% as of Q3 2025, which was up 1,633.61% from 0.00% recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's Return on Invested Capital's 5-year high stood at 0.05% during Q3 2025, with a 5-year trough of -0.06% in Q2 2024.
  • Moreover, its 3-year median value for Return on Invested Capital was -0.04% (2024), whereas its average is -0.02%.
  • Data for Kiniksa Pharmaceuticals International's Return on Invested Capital shows a peak YoY increased of 11bps (in 2025) over the last 5 years.
  • Kiniksa Pharmaceuticals International's Return on Invested Capital (Quarterly) stood at -0.04% in 2023, then reached -0.06% in 2024, then increased by 11bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q3 2025, 0.00% for Q2 2025, and -0.06% during Q3 2024.